Login to Your Account



LATE-STAGE PSEUDOMONAS BLOCKER

Bug bidders to bite? Sanofi give-back opens door to replacement partner for Kalobios

By Randy Osborne
Staff Writer

Tuesday, July 29, 2014

Kalobios Pharmaceuticals Inc. asked for and got back the rights to KB001-A from Sanofi Pasteur, under terms that at least one analyst deemed "attractive" – especially given that the pharma partner was hardly moving the antibody along at a brisk pace.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription